More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$141505734
EPS
3.32
P/E ratio
13
Price to sales
2.02
Dividend yield
--
Beta
-0.087352
Previous close
$43.57
Today's open
$43.50
Day's range
$42.67 - $44.49
52 week range
$23.47 - $70.26
show more
CEO
Richard L. Van Kirk
Employees
148
Headquarters
Irvine, CA
Exchange
NASDAQ Capital Market
Shares outstanding
3262004
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results
IRVINE, CA / ACCESS Newswire / October 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 first quarter ended September 30, 2025.
Accesswire • Oct 30, 2025

Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top Estimates
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.75 per share a year ago.
Zacks Investment Research • Oct 30, 2025

Pro-Dex, Inc. Announces Clarification Related to Trading Symbol
IRVINE, CA / ACCESS Newswire / October 16, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this press release in an effort to help avoid any confusion in the marketplace between the common stock of Pro-Dex, Inc., which trades on the Nasdaq Capital Market under the symbol PDEX, and Polkadex, which to Pro-Dex, Inc.'s understanding trades on certain crypto exchanges (and possibly on certain other platforms) under the same symbol.
Accesswire • Oct 16, 2025

Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESS Newswire / September 4, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 fourth quarter and full-year ended June 30, 2025.
Accesswire • Sep 4, 2025

Pro-Dex, Inc. (PDEX) Lags Q4 Earnings and Revenue Estimates
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.46 per share a year ago.
Zacks Investment Research • Sep 4, 2025

Strength Seen in ProDex (PDEX): Can Its 8.2% Jump Turn into More Strength?
ProDex (PDEX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks Investment Research • Jul 29, 2025

New Strong Buy Stocks for July 1st
NGD, GECC, MITSY, CWEN and PDEX have been added to the Zacks Rank #1 (Strong Buy) List on July 1, 2025.
Zacks Investment Research • Jul 1, 2025

Best Value Stocks to Buy for July 1st
MITSY, NGD and PDEX made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 1, 2025.
Zacks Investment Research • Jul 1, 2025

ProDex (PDEX) Upgraded to Buy: Here's Why
ProDex (PDEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research • Jun 17, 2025

Here is Why Growth Investors Should Buy ProDex (PDEX) Now
ProDex (PDEX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks Investment Research • Jun 17, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Pro-Dex Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.